Document is current
Any future updates will be listed below
-
Authors
Zhang, Lingling
Elkahal, Jacob https://orcid.org/0000-0003-0157-7162
Wang, Tianzhen
Rimmer, Racheli
Genzelinakh, Alexander
Bassat, Elad
Wang, Jingkui
Perez, Dahlia
Kain, David
Lendengolts, Daria
Winkler, Roni
Bueno-levy, Hanna
Umansky, Kfir Baruch https://orcid.org/0000-0003-0541-3069
Mishaly, David
Shakked, Avraham
Miyara, Shoval https://orcid.org/0000-0002-9003-046X
Sarusi-Portuguez, Avital https://orcid.org/0000-0002-0628-1443
Goldfinger, Naomi
Prior, Amir
Morgenstern, David
Levin, Yishai
Addadi, Yoseph https://orcid.org/0000-0001-9827-0436
Li, Baoguo
Rotter, Varda
Katz, Uriel
Tanaka, Elly M. https://orcid.org/0000-0003-4240-2158
Krizhanovsky, Valery
Sarig, Rachel https://orcid.org/0000-0002-4132-5114
Tzahor, Eldad https://orcid.org/0000-0002-5212-9426
- License Information
-
More Information
Article History
Received: 1 May 2023
Accepted: 16 May 2024
First Online: 14 June 2024
Competing interests
: E.T. is a founder and advisor for a biomedical company specializing in advancing agrin therapy for heart diseases. K.B.U. is a co-founder and employee of the same biomedical company. All other authors declare no competing interests.
